Washington, DC--A federal district judge Monday ruled in favor of two Christian doctors today by blocking federal funded research on embryonic stem cells. The judge said a 2009 executive order issued by President Obama that expanded embryonic stem cell research violates a ban on federal money being used to destroy embryos.
Bioethicist and biomedical researcher Kevin FitzGerald, SJ, PhD, is pleased with the judge’s decision which he says protects human life. FitzGerald, a Jesuit priest, is available to comment to the media about the ruling.
FitzGerald is a research associate professor in the Division of Biochemistry and Pharmacology of the Department of Oncology. He holds the Dr. David P. Lauler Chair for Catholic Health Care Ethics. He is also a member of the Center for Clinical Bioethics, the Advisory Board for the Center for Infectious Disease (CID), and the Angiogenesis, Invasion, Metastasis Program at the Lombardi Comprehensive Cancer Center.
His research interests have included the investigation of abnormal gene regulation in cancer and ethical issues in human genetics, including the ethical and social ramifications of molecular genetics research. He is an expert on ethical issues in personalized medicine, pharmacogenomics, human cloning research, and genetic testing in addition to stem cell research.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis -- or "care of the whole person." The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university’s sponsored research funding.